Short Interest in Hypermarcas (OTCMKTS:HYPMY) Drops By 99.0%

Key Points

• Short interest in Hypermarcas has plummeted by 99.0%, falling from 10,400 shares to just 100 shares as of August 31st.
• Analysts have upgraded Hypermarcas to a "strong-buy" rating, contributing to an overall average rating of "Strong Buy."
• The company recently declared a dividend yield of 281.0%, set to be paid on January 8th, with a payout ratio of 57.14%.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was the target of a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 100 shares, a decline of 99.0% from the August 15th total of 10,400 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily trading volume, of 89,400 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 89,400 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company's stock are sold short.

Analysts Set New Price Targets

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a report on Thursday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat, Hypermarcas currently has an average rating of "Strong Buy".

Hypermarcas Stock Performance

OTCMKTS HYPMY traded down $0.12 on Thursday, hitting $4.32. 7,803 shares of the company's stock were exchanged, compared to its average volume of 70,440. The firm has a market cap of $2.74 billion, a price-to-earnings ratio of 20.57 and a beta of 0.86. The firm's 50-day moving average price is $4.53 and its two-hundred day moving average price is $4.13. Hypermarcas has a fifty-two week low of $2.64 and a fifty-two week high of $5.36. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be paid a $0.0345 dividend. The ex-dividend date is Monday, June 30th. This represents a dividend yield of 281.0%. Hypermarcas's dividend payout ratio (DPR) is 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.